{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:03:29Z","timestamp":1784084609529,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032760","name":"PROCEPT BioRobotics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02180-8","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:45:07Z","timestamp":1779194707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aquablation for dual burden disease - BPH and chronic prostatitis\/chronic pelvic pain syndrome: a single-center prospective pilot study"],"prefix":"10.1186","volume":"26","author":[{"given":"Asem F.","family":"Ghanim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Covas","family":"Moschovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Injiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chiriboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Allegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2180_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jama.2010.1913","volume":"305","author":"T Anothaisintawee","year":"2011","unstructured":"Anothaisintawee T, Attia J, Nickel JC, Thammakraisorn S, Numthavaj P, McEvoy M, et al. Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011;305:78\u201386. https:\/\/doi.org\/10.1001\/jama.2010.1913.","journal-title":"JAMA"},{"key":"2180_CR2","doi-asserted-by":"publisher","first-page":"e22151","DOI":"10.1097\/MD.0000000000022151","volume":"99","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhang L, Shen Y, Yao H, Yong S, You Y. Effectiveness of psychological interventions for treating chronic prostatitis\/chronic pelvic pain syndrome: a protocol for systematic review and meta-analysis. Med (Baltim). 2020;99:e22151. https:\/\/doi.org\/10.1097\/MD.0000000000022151.","journal-title":"Med (Baltim)"},{"key":"2180_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.282.3.236","volume":"282","author":"JN Krieger","year":"1999","unstructured":"Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236\u20137.","journal-title":"JAMA"},{"key":"2180_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1468-3083.2002.00481.x","volume":"16","author":"GA Luzzi","year":"2002","unstructured":"Luzzi GA. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management. J Eur Acad Dermatol Venereol. 2002;16:253\u20136. https:\/\/doi.org\/10.1046\/j.1468-3083.2002.00481.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2180_CR5","first-page":"290","volume":"93","author":"JD Holt","year":"2016","unstructured":"Holt JD, Garrett WA, McCurry TK, Teichman JMH. Common questions about chronic prostatitis. Am Fam Physician. 2016;93:290\u20136.","journal-title":"Am Fam Physician"},{"key":"2180_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/iju.15149","volume":"30","author":"K Maeda","year":"2023","unstructured":"Maeda K, Shigemura K, Fujisawa M. A review of current treatments for chronic prostatitis\/chronic pelvic pain syndrome under the UPOINTS system. Int J Urol. 2023;30:431\u20136. https:\/\/doi.org\/10.1111\/iju.15149.","journal-title":"Int J Urol"},{"key":"2180_CR7","first-page":"1802","volume":"2015","author":"DK Bowen","year":"2015","unstructured":"Bowen DK, Dielubanza E, Schaeffer AJ. Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid. 2015;2015:1802.","journal-title":"BMJ Clin Evid"},{"key":"2180_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bju.13101","volume":"116","author":"J Rees","year":"2015","unstructured":"Rees J, Abrahams M, Doble A, Cooper A, Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis\/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015;116:509\u201325. https:\/\/doi.org\/10.1111\/bju.13101.","journal-title":"BJU Int"},{"issue":"Suppl 1","key":"2180_CR9","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.ijantimicag.2007.08.028","volume":"31","author":"JN Krieger","year":"2008","unstructured":"Krieger JN, Lee SWH, Jeon J, Cheah PY, Liong ML, Riley DE. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;31(Suppl 1):S85\u201390. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.028.","journal-title":"Int J Antimicrob Agents"},{"key":"2180_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","volume":"159","author":"MM Collins","year":"1998","unstructured":"Collins MM, Stafford RS, O\u2019Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224\u20138.","journal-title":"J Urol"},{"key":"2180_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0090-4295(99)00205-8","volume":"54","author":"JC Nickel","year":"1999","unstructured":"Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology. 1999;54:229\u201333. https:\/\/doi.org\/10.1016\/S0090-4295(99)00205-8.","journal-title":"Urology"},{"key":"2180_CR12","first-page":"14","volume":"10","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol. 2008;10:14\u201325.","journal-title":"Rev Urol"},{"issue":"Suppl 3","key":"2180_CR13","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.5489\/cuaj.5325","volume":"12","author":"RC Doiron","year":"2018","unstructured":"Doiron RC, Nickel JC. Management of chronic prostatitis\/chronic pelvic pain syndrome. Can Urol Assoc J. 2018;12(Suppl 3):S161\u20133. https:\/\/doi.org\/10.5489\/cuaj.5325.","journal-title":"Can Urol Assoc J"},{"key":"2180_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00345-017-2054-0","volume":"35","author":"DS Schoeb","year":"2017","unstructured":"Schoeb DS, Schlager D, Boeker M, Wetterauer U, Schoenthaler M, Herrmann TRW, et al. Surgical therapy of prostatitis: a systematic review. World J Urol. 2017;35:1659\u201368. https:\/\/doi.org\/10.1007\/s00345-017-2054-0.","journal-title":"World J Urol"},{"key":"2180_CR15","doi-asserted-by":"publisher","unstructured":"Nickel JC. Treatment of chronic prostatitis\/chronic pelvic pain syndrome. Int J Antimicrob Agents. 2008;31(Suppl 1):S112-6. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.07.028.","DOI":"10.1016\/j.ijantimicag.2007.07.028"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"e088848","DOI":"10.1136\/bmjopen-2024-088848","volume":"14","author":"Z Qin","year":"2024","unstructured":"Qin Z, Zhang C, Wei X, Cui J, Yu Y, Pang R, et al. Comparative efficacy of non-pharmacological management for chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis protocol. BMJ Open. 2024;14:e088848. https:\/\/doi.org\/10.1136\/bmjopen-2024-088848.","journal-title":"BMJ Open"},{"key":"2180_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/01.mou.0000193365.46081.cd","volume":"16","author":"JC Nickel","year":"2006","unstructured":"Nickel JC. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr Opin Urol. 2006;16:5\u201310. https:\/\/doi.org\/10.1097\/01.mou.0000193365.46081.cd.","journal-title":"Curr Opin Urol"},{"key":"2180_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.urology.2007.11.155","volume":"71","author":"JL St Sauver","year":"2008","unstructured":"St Sauver JL, Jacobson DJ, McGree ME, Girman CJ, Lieber MM, Jacobsen SJ. Longitudinal association between prostatitis and development of benign prostatic hyperplasia. Urology. 2008;71:475\u20139. https:\/\/doi.org\/10.1016\/j.urology.2007.11.155. discussion 479.","journal-title":"Urology"},{"key":"2180_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/iju.15518","volume":"31","author":"S Inamura","year":"2024","unstructured":"Inamura S, Terada N. Chronic inflammation in benign prostatic hyperplasia: pathophysiology and treatment options. Int J Urol. 2024;31:968\u201374. https:\/\/doi.org\/10.1111\/iju.15518.","journal-title":"Int J Urol"},{"key":"2180_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/pros.23257","volume":"77","author":"Y Funahashi","year":"2017","unstructured":"Funahashi Y, Majima T, Matsukawa Y, Yamamoto T, Yoshida M, Gotoh M. Intraprostatic reflux of urine induces inflammation in a rat. Prostate. 2017;77:164\u201372. https:\/\/doi.org\/10.1002\/pros.23257.","journal-title":"Prostate"},{"key":"2180_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1124\/jpet.123.002081","volume":"390","author":"S Ashraf","year":"2024","unstructured":"Ashraf S, Clarkson T, Malykhina AP. Therapeutic approaches for urologic chronic pelvic pain syndrome: management, research advances, experimental targets, and future directions. J Pharmacol Exp Ther. 2024;390:222\u201332. https:\/\/doi.org\/10.1124\/jpet.123.002081.","journal-title":"J Pharmacol Exp Ther"},{"key":"2180_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5534\/wjmh.220248","volume":"42","author":"H He","year":"2024","unstructured":"He H, Luo H, Qian B, Xu H, Zhang G, Zou X, et al. Autonomic nervous system dysfunction is related to chronic prostatitis\/chronic pelvic pain syndrome. World J Mens Health. 2024;42:1\u201328. https:\/\/doi.org\/10.5534\/wjmh.220248.","journal-title":"World J Mens Health"},{"key":"2180_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549\u201357. https:\/\/doi.org\/10.1016\/S0022-5347(17)36966-5. discussion 1564.","journal-title":"J Urol"},{"key":"2180_CR24","first-page":"1","volume":"7","author":"MP O\u2019Leary","year":"2005","unstructured":"O\u2019Leary MP. Validity of the bother score in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Rev Urol. 2005;7:1\u201310.","journal-title":"Rev Urol"},{"key":"2180_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/pcan.2009.22","volume":"12","author":"JQ Clemens","year":"2009","unstructured":"Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Dunn RL, Crowley EM, et al. Rescoring the NIH Chronic Prostatitis Symptom Index (NIH-CPSI): nothing new. Prostate Cancer Prostatic Dis. 2009;12:285\u20137. https:\/\/doi.org\/10.1038\/pcan.2009.22.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2180_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","volume":"162","author":"MS Litwin","year":"1999","unstructured":"Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369\u201375. https:\/\/doi.org\/10.1016\/S0022-5347(05)68562-X.","journal-title":"J Urol"},{"key":"2180_CR27","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"P Gilling","year":"2018","unstructured":"Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: a double-blind, randomized, controlled trial of Aquablation\u00ae vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. 2018;199:1252\u201361. https:\/\/doi.org\/10.1016\/j.juro.2017.12.065.","journal-title":"J Urol"},{"key":"2180_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/JU.0000000000003483","volume":"210","author":"N Bhojani","year":"2023","unstructured":"Bhojani N, Bidair M, Kramolowsky E, Desai M, Doumanian L, Zorn KC, et al. Aquablation therapy in large prostates (80\u2013150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results. J Urol. 2023;210:143\u201353. https:\/\/doi.org\/10.1097\/JU.0000000000003483.","journal-title":"J Urol"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5213\/inj.2011.15.3.172","volume":"15","author":"DS Kim","year":"2011","unstructured":"Kim DS, Kyung YS, Woo SH, Chang YS, Kim HJ. Efficacy of anticholinergics for chronic prostatitis\/chronic pelvic pain syndrome in young and middle-aged patients: a single-blinded, prospective, multi-center study. Int Neurourol J. 2011;15:172\u20135. https:\/\/doi.org\/10.5213\/inj.2011.15.3.172.","journal-title":"Int Neurourol J"},{"key":"2180_CR30","first-page":"10378","volume":"27","author":"A Kasraeian","year":"2020","unstructured":"Kasraeian A, Alcantara M, Alcantara KM, Altamirando JA, Kasraeian A. Aquablation for BPH. Can J Urol. 2020;27:10378\u201381.","journal-title":"Can J Urol"},{"key":"2180_CR31","first-page":"17","volume":"28","author":"AT Tokarski","year":"2021","unstructured":"Tokarski AT, Leong JY, Roehrborn CG, Shvero A, Das AK. Aquablation of the prostate: a review and update. Can J Urol. 2021;28:17\u201321.","journal-title":"Can J Urol"},{"key":"2180_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2019.04.029","volume":"129","author":"N Bhojani","year":"2019","unstructured":"Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, et al. Aquablation for benign prostatic hyperplasia in large prostates (80\u2013150\u00a0cc): 1-year results. Urology. 2019;129:1\u20137. https:\/\/doi.org\/10.1016\/j.urology.2019.04.029.","journal-title":"Urology"},{"key":"2180_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/bju.14703","volume":"124","author":"M Desai","year":"2019","unstructured":"Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, et al. Aquablation for benign prostatic hyperplasia in large prostates (80\u2013150 mL): 6-month results from the WATER II trial. BJU Int. 2019;124:321\u20138. https:\/\/doi.org\/10.1111\/bju.14703.","journal-title":"BJU Int"},{"key":"2180_CR34","first-page":"10960","volume":"29","author":"PJ Gilling","year":"2022","unstructured":"Gilling PJ, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol. 2022;29:10960\u20138.","journal-title":"Can J Urol"},{"key":"2180_CR35","first-page":"11650","volume":"30","author":"K Oumedjbeur","year":"2023","unstructured":"Oumedjbeur K, Corsi NJ, Bouhadana D, Ibrahim A, Nguyen DD, Matta I, et al. Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate 50\u201380 mL. Can J Urol. 2023;30:11650\u20138.","journal-title":"Can J Urol"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211:11\u20139. https:\/\/doi.org\/10.1097\/JU.0000000000003698.","journal-title":"J Urol"},{"key":"2180_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","volume":"15","author":"KJ Propert","year":"2006","unstructured":"Propert KJ, Litwin MS, Wang Y, Alexander RB, Calhoun E, Nickel JC, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006;15:299\u2013305. https:\/\/doi.org\/10.1007\/s11136-005-1317-1.","journal-title":"Qual Life Res"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.jiac.2025.102647","volume":"31","author":"Y Togo","year":"2025","unstructured":"Togo Y, Yoshioka S, Kaizuka Y, Nagasawa S. Effectiveness of transurethral enucleation with bipolar for benign prostatic hyperplasia patients with chronic prostatitis\/chronic pelvic pain syndrome - single center retrospective study. J Infect Chemother. 2025;31:102647. https:\/\/doi.org\/10.1016\/j.jiac.2025.102647.","journal-title":"J Infect Chemother"},{"key":"2180_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00345-025-06141-y","volume":"44","author":"N Lee","year":"2026","unstructured":"Lee N, Bouhadana D, Sioufi J, Chakraborty A, Murad L, Marhamati S, et al. Real-world outcomes of aquablation for benign prostatic hyperplasia: a comparative analysis of the international collaborative aquablation research urology society (ICARUS) database, WATER and WATER-II trials. World J Urol. 2026;44:146. https:\/\/doi.org\/10.1007\/s00345-025-06141-y.","journal-title":"World J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02180-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02180-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02180-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:05:20Z","timestamp":1784081120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02180-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02180-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8854260\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved human participants and was reviewed and approved by the AdventHealth Institutional Review Board (IRB reference number: 2070285). Written informed consent was obtained from all participants prior to enrollment. All procedures were conducted in accordance with the ethical standards of the responsible institutional committee and with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not contain any individual person\u2019s identifiable data, images, or videos. Therefore, consent for publication was not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"163"}}